Recalls / Active ingredient / Ampicillin Sodium
Ampicillin Sodium
5 FDA drug recalls involving the active ingredient “Ampicillin Sodium” — 2 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-04-13 | Class II | Ampicillin for Injection, USP, 1 g per vial, 10-count box, Rx only, Distributed by: Auromedics Pharma, NDC 551 | Mckesson Medical-Surgical Inc. Corporate Office |
| 2020-05-29 | Class II | Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy | Pfizer Inc. |
| 2018-05-01 | Class I | Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Man | AuroMedics Pharma LLC |
| 2018-01-02 | Class I | Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Dis | Aurobindo Pharma Ltd. |
| 2017-09-25 | Class III | Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wra | Sandoz Inc |